Bank Of Montreal Anavex Life Sciences Corp. Transaction History
Bank Of Montreal
- $192 Billion
- Q1 2025
A detailed history of Bank Of Montreal transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Bank Of Montreal holds 19,879 shares of AVXL stock, worth $154,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,879
Previous 19,879
-0.0%
Holding current value
$154,658
Previous $213,000
20.19%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AVXL
# of Institutions
203Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$49.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$38.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$15.3 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$7.78 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $606M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...